000			01638 a2200457 4500
005			20250517100504.0
264		0	_c20180925
008			201809s 0 0 eng d
022			_a1365-2265
024	7		_a10.1111/cen.13120 _2doi
040			_aNLM _beng _cNLM
100	1		_aSathyapalan, Thozhukat
245	0	0	_aEndocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome. _h[electronic resource]
260			_bClinical endocrinology _cOct 2016
300			_a671-3 p. _bdigital
500			_aPublication Type: Letter; Randomized Controlled Trial
650	0	4	_aBody Mass Index
650	0	4	_aCannabinoid Receptor Antagonists _xtherapeutic use
650	0	4	_aCytokines _xblood
650	0	4	_aFemale
650	0	4	_aHepatocyte Growth Factor _xblood
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aInsulin _xtherapeutic use
650	0	4	_aInsulin Resistance
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aNon-alcoholic Fatty Liver Disease _xblood
650	0	4	_aObesity _xblood
650	0	4	_aPiperidines _xtherapeutic use
650	0	4	_aPolycystic Ovary Syndrome _xblood
650	0	4	_aPyrazoles _xtherapeutic use
650	0	4	_aRimonabant
700	1		_aDakroury, Youssra
700	1		_aAhmed, Lina
700	1		_aElshewehy, Abeer M M
700	1		_aKilpatrick, Eric S
700	1		_aCoady, Anne-Marie
700	1		_aAtkin, Stephen L
773	0		_tClinical endocrinology _gvol. 85 _gno. 4 _gp. 671-3
856	4	0	_uhttps://doi.org/10.1111/cen.13120 _zAvailable from publisher's website
999			_c26086257 _d26086257